COHR renames business units

Article

Independent service organization COHR of Chatsworth, CA, announced last month new names for two of its business units. The company reported that following the separation of COHR Masterplan as a stand-alone business unit (SCAN 4/28/99), the

Independent service organization COHR of Chatsworth, CA, announced last month new names for two of its business units. The company reported that following the separation of COHR Masterplan as a stand-alone business unit (SCAN 4/28/99), the new entity will be known simply as Masterplan. COHR also appointed Bruce Cree and George Farley to Masterplan’s newly formed board of directors. Cree is Masterplan’s president and CEO, as well as chairman of the board, while Farley is vice chairman.

Another of COHR’s businesses, Purchase Connection, changed its name last month to InSource Health Services. The company announced the change at its annual meeting in New Orleans. COHR was acquired in March by Three Cities Research, an investment adviser firm in New York City (SCAN 3/17/99). The transaction made COHR a private firm.

© 1999 Miller Freeman, Inc.All rights reserved.

Recent Videos
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
Related Content
© 2025 MJH Life Sciences

All rights reserved.